Buy 3-Me-PCPy (3-Methylrolicyclidine) | Technical Profile & Research Data

Looking for technical information on buy 3-Me-PCPy? 3-Methylrolicyclidine (3-Me-PCPy) is a high-potency dissociative compound belonging to the arylcyclohexylamine class. As a structural isomer of PCP (Phencyclidine), it is a critical subject for researchers investigating the complex interplay between NMDA antagonism and monoamine reuptake inhibition.

Due to its high potency and distinct pharmacological profile, 3-Me-PCPy is utilized strictly in controlled forensic, academic, and scientific research environments.

Pharmacological Profile & Mechanism of Action

3-Me-PCPy is distinguished from other arylcyclohexylamines by its multifaceted interaction with the central nervous system. Research indicates that it acts as both an NMDA receptor antagonist and a triple reuptake inhibitor (TRI).

Glutamatergic Modulation: Like PCP, it blocks NMDA receptors, disrupting normal neural signaling and inducing dissociative states.
Monoamine Interaction: It inhibits the reuptake of serotonin, norepinephrine, and dopamine, making it a subject of interest for studies on stimulant-dissociative synergies.
Structural Significance: As an isomer of PCP, it provides unique data for structural activity relationship (SAR) studies regarding the impact of methyl substitutions on the phenyl ring.

Technical Specifications

Property	Details
Chemical Name	3-Methylrolicyclidine (3-Me-PCPy)
Chemical Class	Arylcyclohexylamine / Isomer of PCP
Mechanism	NMDA Antagonist & Triple Reuptake Inhibitor
Purity Grade	High-Purity Research Grade (typically $\geq$ 98%)
Primary Use	Forensic Toxicology & Neurochemical Research

Global Legal Status & Regulatory Compliance

The acquisition and possession of 3-Me-PCPy are subject to strict international regulations. It is generally restricted to industrial or sanctioned scientific use:

United States: Subject to the Federal Analogue Act if intended for human consumption due to its similarity to Schedule I/II substances.
United Kingdom: Classified as a Class B controlled substance under the Misuse of Drugs Act.
Canada: Listed as a Schedule I drug.
Germany: Regulated under the NpSG (New Psychoactive Substances Act), restricting use to specific scientific purposes.

Health Hazards & Toxicological Risks

3-Me-PCPy is strictly not for human or veterinary consumption. Toxicological research has identified significant risks associated with this compound:

Neurological Impact: Potential for severe psychosis, vivid hallucinations, and acute agitation.
Cardiovascular Strain: Documented risk of tachycardia and hypertensive crisis.
Overdose Risk: High potential for fatal toxicity, consistent with other potent PCP analogs.